RegeneRx Biopharmaceuticals (RGRX)
OTHER OTC:RGRX
US Market
Holding RGRX?
Track your performance easily

RegeneRx Biopharmaceuticals (RGRX) Stock Price & Analysis

82 Followers

RGRX Stock Chart & Stats


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

RGRX FAQ

What was RegeneRx Biopharmaceuticals’s price range in the past 12 months?
RegeneRx Biopharmaceuticals lowest stock price was $0.05 and its highest was $0.06 in the past 12 months.
    What is RegeneRx Biopharmaceuticals’s market cap?
    Currently, no data Available
    When is RegeneRx Biopharmaceuticals’s upcoming earnings report date?
    RegeneRx Biopharmaceuticals’s upcoming earnings report date is May 15, 2018 which is 2375 days ago.
      How were RegeneRx Biopharmaceuticals’s earnings last quarter?
      Currently, no data Available
      Is RegeneRx Biopharmaceuticals overvalued?
      According to Wall Street analysts RegeneRx Biopharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does RegeneRx Biopharmaceuticals pay dividends?
        RegeneRx Biopharmaceuticals does not currently pay dividends.
        What is RegeneRx Biopharmaceuticals’s EPS estimate?
        RegeneRx Biopharmaceuticals’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does RegeneRx Biopharmaceuticals have?
        RegeneRx Biopharmaceuticals has 1,496,966 shares outstanding.
          What happened to RegeneRx Biopharmaceuticals’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of RegeneRx Biopharmaceuticals?
          Currently, no hedge funds are holding shares in RGRX
          ---

          RegeneRx Biopharmaceuticals Stock Smart Score

          10
          Unlock Smart Score
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Company Description

          RegeneRx Biopharmaceuticals

          RegeneRx Biopharmaceuticals, Inc. focuses on the development of a novel therapeutic peptide, Thymosin beta 4, or Tß4, for tissue and organ protection, repair, and regeneration. Its products include RGN-259, RGN-352, and RGN-137. The company was founded by Allan L. Goldstein on May 13, 1982 and is headquartered in Rockville, MD.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Cellectar Biosciences
          Genprex
          Microbot Medical
          Brainstorm Cell Therapeutics
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis